Clinical Trials Directory

Trials / Completed

CompletedNCT02638831

Ketorol Gel in Gonarthrosis and Low Back Pain

Open Label Randomized Study for Evaluating Efficacy and Safety of Ketorolac Tromethamine and Ketoprofen in Gel in Patients With Gonarthrosis and Low Back Pain

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
240 (actual)
Sponsor
Dr. Reddy's Laboratories Limited · Industry
Sex
All
Age
20 Years – 70 Years
Healthy volunteers
Not accepted

Summary

Comparative clinical study of Ketorolac tromethamineand Ketoprofen gel in patients with Gonarthrosis and Low back pain.

Detailed description

This is a Comparative evaluation of therapeutic efficacy and safety of use of drug Ketorolac tromethamine gel and drug Ketoprofen gel , as an agent of local symptomatic therapy in patients with diseases of musculoskeletal system with associated pain syndrome in outpatient conditions. The study includes patients with moderate pain syndrome in gonarthrosis and lower back pain (LBP). The sample size of 240 was calculated for the main efficacy variable - mean pain intensity according to the visual analogue scale (VAS) in 10 days of therapy. Patients who subjected to inclusion into the study and had signed informed consent will be distributed into the study groups depending on established diagnosis: Gonarthrosis group and LBP group.

Conditions

Interventions

TypeNameDescription
DRUGKetorolac TromethamineKetorolac tromethamine gel 2% for external application. Column of gel about 3-5 cm is applied on the area of maximum pain three times a day for 10 days
DRUGKetoprofenKetoprofen gel 2.5% for external application Column of gel (3-5 cm) is applied with a thin layer on the skin in the area of maximum pain 3 times a day for 10 days

Timeline

Start date
2013-03-01
Primary completion
2013-11-01
Completion
2013-11-01
First posted
2015-12-23
Last updated
2017-03-13

Source: ClinicalTrials.gov record NCT02638831. Inclusion in this directory is not an endorsement.